Early research (Phase 1)Active Not RecruitingNCT06309043
What this trial is testing
A Randomized, Single Intravenous Dose, Parallel Phase I Clinical Study to Compare the Pharmacokinetic Characteristics, Safety, and Immunogenicity of HLX05 Vs. Erbitux® (Cetuximab) in Healthy Adult Male Chinese Subjects
Who this might be right for
EGFR Overexpression
Shanghai Henlius Biotech 268